Ceeto Capital Group LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Ceeto Capital Group LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 3,426 shares of the healthcare conglomerate’s stock after acquiring an additional 100 shares during the quarter. Ceeto Capital Group LLC’s holdings in UnitedHealth Group were worth $1,695,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. True Wealth Design LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $31,000. Delos Wealth Advisors LLC increased its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. LFA Lugano Financial Advisors SA increased its position in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. Red Tortoise LLC increased its holdings in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares during the period. Finally, Transcendent Capital Group LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $10.04 on Friday, hitting $569.72. The company had a trading volume of 3,202,023 shares, compared to its average volume of 5,159,030. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $581.50. The business has a 50 day moving average of $508.82 and a 200 day moving average of $501.19. The company has a market cap of $524.36 billion, a PE ratio of 34.82, a PEG ratio of 1.59 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the business earned $6.14 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on UNH. Wells Fargo & Company boosted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Robert W. Baird boosted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Truist Financial lifted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.